文献速递运动医学关节外科

关节镜下基质诱导自体软骨细胞植入术后10年以上前瞻性临床与MRI随访

A Prospective Clinical and Magnetic Resonance Imaging-Based Follow-up Beyond 10 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation.
PubMed 文献 · Am J Sports Med · 2026-07-17

这项前瞻性病例系列研究纳入45例接受关节镜下基质诱导自体软骨细胞植入(MACI)的股骨髁软骨缺损患者,平均随访13.6年。多数患者报告结局显著改善,100%对疼痛缓解满意,95%对运动能力满意,失败率4.4%;但MRI显示移植物填充、边界整合等指标随时间显著退化。

要点

  • 关节镜下MACI术后平均13.6年患者满意度高,失败率4.4%。
  • 多数PROMs显著改善,内侧与外侧股骨髁间无差异。
  • MRI评分虽总体良好,但移植物填充等指标从5年到末次随访显著退化。

核心结论

  • 关节镜下MACI在术后平均13.6年提供良好的临床结局、患者满意度和移植物存活率。

研究设计与样本

  • 前瞻性病例系列,证据等级4级,共45例患者接受关节镜下MACI。
  • 内侧股骨髁31例(缺损1.0-7.7 cm2),外侧股骨髁14例(缺损1.5-5.0 cm2)。
  • 术前及术后1、2、5年和平均13.6年(范围11-17年)收集结局。

主要发现

  • 大多数PROMs显著改善(P < .0001),内侧与外侧股骨髁间无差异。
  • 末次随访时100%患者对疼痛缓解满意,95%对运动能力满意。
  • 主动膝关节屈曲活动度和伸膝力量肢体对称指数显著改善(P < .0001)。
  • MRI显示移植物填充(P = .040)、边界整合(P = .026)、表面轮廓(P = .012)、组织结构(P = .007)和总体MRI复合评分(P = .029)随时间显著退化。
  • 1例移植物床无修复组织(移植物失败),另1例进展为全膝关节置换,失败率4.4%。

关键数值与推荐

  • MOCART评分工具用于评估移植物参数及总体MRI复合评分。
  • 末次随访时100%患者对疼痛缓解满意,95%对运动能力满意。
  • 失败率4.4%(2例失败,包括1例移植物失败和1例全膝关节置换)。

临床怎么用

  • 关节镜下MACI可作为股骨髁软骨缺损的治疗选择,长期临床效果和满意度良好。
  • 术后长期随访中需关注MRI显示的移植物成熟度退化,尽管临床结果稳定。

局限性

  • 病例系列研究,证据等级4级,无对照组。
  • 样本量较小(45例),随访时间范围较宽(11-17年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term studies are emerging reporting encouraging outcomes after matrix-induced autologous chondrocyte implantation (MACI). While MACI has historically been undertaken via open arthrotomy, arthroscopic techniques have been reported. However, longer term clinical outcomes and/or graft survivorship after arthroscopically performed MACI are yet to be reported. PURPOSE: To present longer term clinical and radiological outcomes in patients after MACI performed arthroscopically on the femoral condyles. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 45 patients were prospectively recruited and underwent arthroscopically performed MACI to the medial femoral condyle (MFC; n = 31; defect size, 1.0-7.7 cm2) or lateral femoral condyle (LFC; n = 14; defect size, 1.5-5.0 cm2). Outcomes were collected before surgery and at 1, 2, and 5 years as well as at a mean of 13.6 years (range, 11-17 years) after surgery. These included scores for a variety of patient-reported outcome measures (PROMs) including the Knee Injury and Osteoarthritis Outcome Score, Lysholm Knee Score, Tegner Activity Scale, and patient satisfaction. Active knee range of motion as well as peak isokinetic knee extensor and flexor strength were assessed, while magnetic resonance imaging (MRI) was undertaken. The Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) scoring tool was employed to grade relevant graft parameters, along with an overall MRI composite score. RESULTS: A significant improvement (P < .0001) was observed on most PROMs, with no differences between patients undergoing MACI to the MFC or LFC. Of those assessed at final follow-up, 100% were satisfied with the ability of MACI to relieve their knee pain, while 95% were satisfied with their ability to participate in sport. Active knee flexion range of motion significantly improved (P < .0001), as did the knee extensor strength limb symmetry index (P < .0001), although no differences were observed based on graft location. Despite encouraging MRI-based scores at final follow-up, a significant deterioration over time was observed for graft infill (P = .040), border integration (P = .026), surface contour (P = .012), tissue structure (P = .007), and the overall MRI composite score (P = .029), largely as a result of mean changes from 5 years to final follow-up. Apart from better scores for subchondral lamina over the period in LFC grafts, no MRI-based differences were observed based on graft location. One patient demonstrated a graft bed devoid of repair tissue, indicating graft failure, and combined with one additional patient who progressed to total knee arthroplasty, a failure rate of 4.4% was observed. CONCLUSION: MACI performed via an arthroscopic approach provided sound clinical outcomes, patient satisfaction, and graft survivorship at a mean 13.6 years after surgery.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ebert JR, Edwards PK, Klinken S, et al. A Prospective Clinical and Magnetic Resonance Imaging-Based Follow-up Beyond 10 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation. Am J Sports Med. 2026. PMID: 42466622. doi:10.1177/03635465261459242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。